Full Text View
Tabular View
No Study Results Posted
Related Studies
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
This study has been completed.
Study NCT00304863   Information provided by VA Medical Center, Houston
First Received: March 16, 2006   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Enterocolitis
Pseudomembranous Colitis
Antibiotic-Associated Colitis
Additional conditions recognized in this trial
Colitis
Enterocolitis, Pseudomembranous
More general conditions related to this trial
Bacterial Infections
Clostridium Infections
Colonic Diseases
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Gram-Positive Bacterial Infections
Intestinal Diseases
Interventions listed in this trial
Lactobacillus GG
Additional drug interventions recognized in this trial
Metronidazole
More general drug interventions related to this trial
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
VA Medical Center, Houston
Baylor College of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services